• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

David M. Jackman, MD

Assistant Professor, Department of Medicine, Harvard Medical School

Medical Director of Clinical Pathways, Medical Oncology, Dana-Farber Cancer Institute

Physician, Lowe Center for Thoracic Oncology, Medical Oncology, Dana-Farber Cancer Institute

Contact Info

David Jackman
Dana-Farber Cancer Institute
450 Brookline Avenue

Boston, MA, 02215
Phone: 617-632-3468
Fax: 617-632-5786


Adele Joseph
Dana-Farber Cancer Institute
Phone: 617-632-3468
Fax: 617-632-5786

DF/HCC Program Affiliation

Lung Cancer

Research Abstract

The development of my career as a thoracic oncologist has been fueled primarily by a desire to improve patient outcomes in lung cancer and mesothelioma. My clinical research efforts have been largely directed at the use of targeted therapies in these diseases. I have played leading roles in several trials assessing the use of small molecule inhibitors of the epidermal growth factor receptor (EGFR) in both non-small cell lung cancer (NSCLC) and mesothlioma. My translational and database work has allowed for a more focused analysis of the impact of specific genotypic changes on clinical outcomes to treatment; an assessment of the use of clinical and molecular predictors of sensitivity; and a comparison of the impact of genotypic changes between populations from Asia vs. US/Europe.

My clinical care of patients with lung cancer and mesothelioma is of great personal importance to me. Everything else in my professional career ultimately stems from that: whether delivering presentations here or abroad to educate other oncologists, mentoring or precepting fellows in our medical oncology clinic, or analyzing the latest results from our clinical trials, I profoundly hope that my efforts will help to improve the lives of these and future patients as we together combat the morbidity of these thoracic malignancies.


View All Publications